Biejia-Ruangan compound

DRUG2 trials

Sponsors

Zhiyun Yang, Nanfang Hospital, Southern Medical University

Conditions

Cirrhosis, LiverHEPATITIS B CHRONICHepatocellular Carcinoma (HCC)

Phase 4

Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment

Not yet recruitingNCT06923176

Zhiyun YangHepatocellular Carcinoma (HCC)

Start: 2025-04-19End: 2031-04-30Target: 704Updated: 2025-04-11

Unknown Phase

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

Not yet recruitingNCT07481032

Nanfang Hospital, Southern Medical UniversityCirrhosis, Liver, HEPATITIS B CHRONIC, Hepatocellular Carcinoma (HCC)

Start: 2026-04-01End: 2028-11-30Target: 1034Updated: 2026-03-18